Geron (GERN) Times Interest Earned (2010 - 2026)
Geron's (GERN) quarterly Times Interest Earned came in at 1.75 in Q2 2026, down 19.57% year-over-year from 2.17 in Q2 2025, and down 8009.97% quarter-over-quarter from 0.02 in Q1 2026.
Powered by 
Analysis
Geron (GERN) Times Interest Earned (2010 - 2026) Analysis & Trends
Geron has disclosed Times Interest Earned across 17 years of filings, most recently posting 1.75 for Q2 2026.
- In Q2 2026, Times Interest Earned fell 19.57% year-over-year to 1.75; the TTM figure through Jun 2026 stood at 1.71 (up 37.05% YoY), while the FY2025 annual figure was 2.1, up 77.63% from the prior year.
- Times Interest Earned came in at 1.75 for Q2 2026 at Geron, down from 0.02 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of 0.02 in Q1 2026 to a low of 25.94 in Q2 2023.
- Average Times Interest Earned over 5 years is 12.91, with a median of 17.02 recorded in 2022.
- Year-over-year, Times Interest Earned plunged 51.98% in 2025 and surged 101.09% in 2026.
- Over 5 years, Times Interest Earned stood at 20.92 in 2022, then fell by 11.79% to 23.39 in 2023, then jumped by 90.15% to 2.3 in 2024, then plunged by 51.98% to 3.5 in 2025, then surged by 50.04% to 1.75 in 2026.
- Per Business Quant data, the three most recent Times Interest Earned figures were 1.75 in Q2 2026, 0.02 in Q1 2026, and 3.5 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 5.22 |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | -42.08 |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 117.59 |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | 493.00 |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 2.82 |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | - |
| 10 | Geron | 914.60 Mn | 613.75 Mn | - | -1.75 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.75 |
| Mar 31, 2026 | 0.02 |
| Dec 31, 2025 | -3.50 |
| Sep 30, 2025 | -1.61 |
| Jun 30, 2025 | -1.46 |
| Mar 31, 2025 | -2.04 |
| Dec 31, 2024 | -2.30 |
| Sep 30, 2024 | -9.26 |
| Jun 30, 2024 | -20.89 |
| Mar 31, 2024 | -16.35 |
| Dec 31, 2023 | -23.39 |
| Sep 30, 2023 | -23.05 |
| Jun 30, 2023 | -25.94 |
| Mar 31, 2023 | -20.86 |
| Dec 31, 2022 | -20.92 |
| Sep 30, 2022 | -21.99 |
| Jun 30, 2022 | -17.70 |
| Mar 31, 2022 | -19.39 |
| Dec 31, 2021 | -27.30 |
| Sep 30, 2021 | -24.27 |